FRUTTERO, Roberta
FRUTTERO, Roberta
SCIENZA E TECNOLOGIA DEL FARMACO
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins
2009-01-01 Loretta Lazzarato; Monica Donnola; Barbara Rolando; Konstantin Chegaev; Elisabetta Marini; Clara Cena; Antonella Di Stilo; Roberta Fruttero; Stefano Biondi; Ennio Ongini; Alberto Gasco
1,2,5-Oxadiazole analogues of leflunomide and related compounds
2011-01-01 Marta Giorgis; Marco Lucio Lolli; Barbara Rolando; Angela Rao; Paolo Tosco; Shilpi Chaurasia; Domenica Marabello; Roberta Fruttero; Alberto Gasco.
13C and 15N Solution and Solid-state Nuclear Magnetic Resonance Study of the Intermolecular interactions in the 1:1 Trimethoprim:Sulphamethoxazole Complex
1988-01-01 R. Fruttero; G.E. Hawkes; E.W. Randall; A. Gasco; C.J. Groombridge
2-Pyridine-ONN-azoxycyanide, C6H4N4O: a Heterocyclic Analogue of Calvatic acid
1984-01-01 D. Viterbo; M. Calleri; R. Calvino; R. Fruttero
4-Hydroxy-1,2,5-oxadiazol-3-yl Moiety as Bioisoster of the Carboxy Function. Synthesis, Ionization Constants, and Molecular Pharmacological Characterization at Ionotropic Glutamate Receptors of Compounds Related to Glutamate and Its Homologues
2010-01-01 Marco L. Lolli; Cecilia Giordano; Darryl S. Pickering; Barbara Rolando; Kasper B. Hansen; Antonio Foti; Alberto Contreras-Sanz; Ahmad Amir; Roberta Fruttero; Alberto Gasco; Birgitte Nielsen; Tommy N. Johansen
4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregation.
1992-01-01 CALVINO R ;FRUTTERO R ;GHIGO D ;BOSIA A ;PESCARMONA GP ;GASCO A
6-Cyclohexylmethoxy-5-(cyano-NNO-azoxy)pyrimidine-4-amine: A new scaffold endowed with potent CDK2 inhibitory activity
2013-01-01 Boschi D.; Tosco P.; Chandra N.; Chaurasia S.; Fruttero R.*; Griffin R.; Wang L.-Z.; Gasco A.
[3-(1H-Imidazol-4-yl)propyl)guanidines Containing Furoxan Moieties: A New Class of H3-Antagonists Endowed with NO-Donor Properties
2003-01-01 BERTINARIA M; DI STILO A; TOSCO P; SORBA G; POLI E; POZZOLI C; CORUZZI G; FRUTTERO R; GASCO A
A cooperation project between hospital pharmacists and general practitioners about drug interactions in clinical practice
2018-01-01 Valeria, Vinciguerra; Roberto, Fantozzi; Clara, Cena; Roberta, Fruttero; Carla, Rolle
A Directed Synthesis of Alkyl, Aryl, and Heteroaryl-ONN-azoxycyanides
1984-01-01 R. Fruttero; G. Mulatero; R. Calvino; A. Gasco
A generator of peroxynitrite activatable with red light
2021-01-01 Parisi C.; Failla M.; Fraix A.; Menilli L.; Moret F.; Reddi E.; Rolando B.; Spyrakis F.; Lazzarato L.; Fruttero R.; Gasco A.; Sortino S.
A Molecular Hybrid for Mitochondria-Targeted NO Photodelivery
2018-01-01 Sodano, Federica; Gazzano, Elena; Fraix, Aurore; Rolando, Barbara; Lazzarato, Loretta; Russo, Marina; Blangetti, Marco; Riganti, Chiara; Fruttero, Roberta; Gasco, Alberto; Sortino, Salvatore
A molecular hybrid producing simultaneously singlet oxygen and nitric oxide by single photon excitation with green light
2019-01-01 Parisi, Cristina; Failla, Mariacristina; Fraix, Aurore; Rescifina, Antonio; Rolando, Barbara; Lazzarato, Loretta*; Cardile, Venera; Graziano, Adriana C.E.; Fruttero, Roberta; Gasco, Alberto; Sortino, Salvatore
A multi-photoresponsive molecular-hybrid for dual-modal photoinactivation of cancer cells
2014-01-01 Aurore Fraix;Stefano Guglielmo;Venera Cardile;Adriana C. E. Graziano;Ruxandra Gref;Barbara Rolando;Roberta Fruttero;Alberto Gasco;Salvatore Sortino
A multitarget approach to optimize the safety profile of coxibs: lumiracoxib derivatives with dual cyclooxygenase-2 inhibitor-thromboxane A2 receptor antagonist activity
2013-01-01 Malvina Hoxha; Valerie Capra; Carola Buccellati; Angelo Sala; Mohammed Abrar Abdul Gaffar Shaikh; Clara Cena; Roberta Fruttero; Alberto Gasco; G. Enrico Rovati; Massimo Bertinaria
A NEW CLASS OF FUROXAN DERIVATIVES AS NO DONORS - MECHANISM OF ACTION AND BIOLOGICAL-ACTIVITY
1995-01-01 FERIOLI R; FOLCO GC; FERRETTI C; GASCO AM; MEDANA C; FRUTTERO R; CIVELLI M; GASCO A
A new class of ibuprofen derivatives with reduced gastrotoxicity
2001-01-01 L. LOLLI; C. CENA; C. MEDANA; L. LAZZARATO; G. MORINI; G. CORUZZI; S. MANARINI; R. FRUTTERO; A. GASCO
A new class of NO-donor H3-Antagonists
2004-01-01 P. Tosco; M. Bertinaria; A. Di Stilo; E. Marini; B. Rolando; G. Sorba; R. Fruttero; A. Gasco
A new furoxan NO-donor rabeprazole derivative and related compounds
2003-01-01 SORBA G; GALLI U; CENA C; FRUTTERO R; GASCO A; MORINI G; ADAMI M; CORUZZI G; BRENCIAGLIA MI; DUBINI F
A New Gateway for Rheumatoid Arthritis: COXIBs with an Improved Cardiovascular Profile
2014-01-01 Hoxha, M.; Capra, V.; Buccellati, C.; Sala, A.; Cena, C.; Fruttero, R.; Bertinaria, M.; Rovati, G.E.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins | 2009 | Loretta Lazzarato; Monica Donnola; Barbara Rolando; Konstantin Chegaev; Elisabetta Marini; Clara Cena; Antonella Di Stilo; Roberta Fruttero; Stefano Biondi; Ennio Ongini; Alberto Gasco | |
1,2,5-Oxadiazole analogues of leflunomide and related compounds | 2011 | Marta Giorgis; Marco Lucio Lolli; Barbara Rolando; Angela Rao; Paolo Tosco; Shilpi Chaurasia; Domenica Marabello; Roberta Fruttero; Alberto Gasco. | |
13C and 15N Solution and Solid-state Nuclear Magnetic Resonance Study of the Intermolecular interactions in the 1:1 Trimethoprim:Sulphamethoxazole Complex | 1988 | R. Fruttero; G.E. Hawkes; E.W. Randall; A. Gasco; C.J. Groombridge | |
2-Pyridine-ONN-azoxycyanide, C6H4N4O: a Heterocyclic Analogue of Calvatic acid | 1984 | D. Viterbo; M. Calleri; R. Calvino; R. Fruttero | |
4-Hydroxy-1,2,5-oxadiazol-3-yl Moiety as Bioisoster of the Carboxy Function. Synthesis, Ionization Constants, and Molecular Pharmacological Characterization at Ionotropic Glutamate Receptors of Compounds Related to Glutamate and Its Homologues | 2010 | Marco L. Lolli; Cecilia Giordano; Darryl S. Pickering; Barbara Rolando; Kasper B. Hansen; Antonio Foti; Alberto Contreras-Sanz; Ahmad Amir; Roberta Fruttero; Alberto Gasco; Birgitte Nielsen; Tommy N. Johansen | |
4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregation. | 1992 | CALVINO R ;FRUTTERO R ;GHIGO D ;BOSIA A ;PESCARMONA GP ;GASCO A | |
6-Cyclohexylmethoxy-5-(cyano-NNO-azoxy)pyrimidine-4-amine: A new scaffold endowed with potent CDK2 inhibitory activity | 2013 | Boschi D.; Tosco P.; Chandra N.; Chaurasia S.; Fruttero R.*; Griffin R.; Wang L.-Z.; Gasco A. | |
[3-(1H-Imidazol-4-yl)propyl)guanidines Containing Furoxan Moieties: A New Class of H3-Antagonists Endowed with NO-Donor Properties | 2003 | BERTINARIA M; DI STILO A; TOSCO P; SORBA G; POLI E; POZZOLI C; CORUZZI G; FRUTTERO R; GASCO A | |
A cooperation project between hospital pharmacists and general practitioners about drug interactions in clinical practice | 2018 | Valeria, Vinciguerra; Roberto, Fantozzi; Clara, Cena; Roberta, Fruttero; Carla, Rolle | |
A Directed Synthesis of Alkyl, Aryl, and Heteroaryl-ONN-azoxycyanides | 1984 | R. Fruttero; G. Mulatero; R. Calvino; A. Gasco | |
A generator of peroxynitrite activatable with red light | 2021 | Parisi C.; Failla M.; Fraix A.; Menilli L.; Moret F.; Reddi E.; Rolando B.; Spyrakis F.; Lazzarato L.; Fruttero R.; Gasco A.; Sortino S. | |
A Molecular Hybrid for Mitochondria-Targeted NO Photodelivery | 2018 | Sodano, Federica; Gazzano, Elena; Fraix, Aurore; Rolando, Barbara; Lazzarato, Loretta; Russo, Marina; Blangetti, Marco; Riganti, Chiara; Fruttero, Roberta; Gasco, Alberto; Sortino, Salvatore | |
A molecular hybrid producing simultaneously singlet oxygen and nitric oxide by single photon excitation with green light | 2019 | Parisi, Cristina; Failla, Mariacristina; Fraix, Aurore; Rescifina, Antonio; Rolando, Barbara; Lazzarato, Loretta*; Cardile, Venera; Graziano, Adriana C.E.; Fruttero, Roberta; Gasco, Alberto; Sortino, Salvatore | |
A multi-photoresponsive molecular-hybrid for dual-modal photoinactivation of cancer cells | 2014 | Aurore Fraix;Stefano Guglielmo;Venera Cardile;Adriana C. E. Graziano;Ruxandra Gref;Barbara Rolando;Roberta Fruttero;Alberto Gasco;Salvatore Sortino | |
A multitarget approach to optimize the safety profile of coxibs: lumiracoxib derivatives with dual cyclooxygenase-2 inhibitor-thromboxane A2 receptor antagonist activity | 2013 | Malvina Hoxha; Valerie Capra; Carola Buccellati; Angelo Sala; Mohammed Abrar Abdul Gaffar Shaikh; Clara Cena; Roberta Fruttero; Alberto Gasco; G. Enrico Rovati; Massimo Bertinaria | |
A NEW CLASS OF FUROXAN DERIVATIVES AS NO DONORS - MECHANISM OF ACTION AND BIOLOGICAL-ACTIVITY | 1995 | FERIOLI R; FOLCO GC; FERRETTI C; GASCO AM; MEDANA C; FRUTTERO R; CIVELLI M; GASCO A | |
A new class of ibuprofen derivatives with reduced gastrotoxicity | 2001 | L. LOLLI; C. CENA; C. MEDANA; L. LAZZARATO; G. MORINI; G. CORUZZI; S. MANARINI; R. FRUTTERO; A. GASCO | |
A new class of NO-donor H3-Antagonists | 2004 | P. Tosco; M. Bertinaria; A. Di Stilo; E. Marini; B. Rolando; G. Sorba; R. Fruttero; A. Gasco | |
A new furoxan NO-donor rabeprazole derivative and related compounds | 2003 | SORBA G; GALLI U; CENA C; FRUTTERO R; GASCO A; MORINI G; ADAMI M; CORUZZI G; BRENCIAGLIA MI; DUBINI F | |
A New Gateway for Rheumatoid Arthritis: COXIBs with an Improved Cardiovascular Profile | 2014 | Hoxha, M.; Capra, V.; Buccellati, C.; Sala, A.; Cena, C.; Fruttero, R.; Bertinaria, M.; Rovati, G.E. |